Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Biosynthesis: The Science That May Unlock The Medical Potential Of Cannabis

2017-12-08 valuewalk
With the birth of legal recreational markets in places like California and a growing appreciation for the medical applications of cannabinoids such as CBD, the floodgates are open for companies to pursue new and groundbreaking opportunities in the sector. (6-1)

The State Of Marijuana Stocks And What To Look For In 2018

2017-11-22 seekingalpha
The secret's out: the cannabis industry continues to grow at an above average pace and now we're seeing even bigger names get involved. Right now, is a very important time to be paying attention to this arena and for good reason. (48-6)

NetworkNewsWire Announces Publication Outlining Innovations Driving Value in Cannabis Industry

2017-11-16 marketwired
NEW YORK, NY--(Marketwired - Nov 16, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. (6-0)

NetworkNewsWire Announces Publication Featuring Innovative Approach to Cannabis R&D

2017-11-15 marketwired
NEW YORK, NY--(Marketwired - Nov 15, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a preclinical stage biopharmaceutical company specializing in the research and development of novel, cannabinoid-based prescription drug therapies utilizing novel drug delivery systems. (6-0)

NetworkNewsWire Announces Publication that Highlights Big Pharma's Increasing Interest in Cannabis Biotech Companies

2017-11-09 marketwired
NEW YORK, NY--(Marketwired - Nov 9, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a client of NNW specializing in a proprietary in-house cannabinoid biosynthesis platform capable of producing any of the 90+ "downstream" cannabinoids that occur naturally in the cannabis plant. (6-0)

NetworkNewsWire Announces Publication Highlighting Big Pharma's Appetite for M&A Possibilities in Cannabis

2017-11-08 marketwired
NEW YORK, NY--(Marketwired - Nov 8, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a client of NNW specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. (58-0)

CFN Media Exclusive CEO Interview: InMed Pharmaceuticals' Biosynthesis Platform Results in an Industry First

2017-11-06 marketwired
SEATTLE, WA--(Marketwired - Nov 6, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media network dedicated to legal cannabis, announces publication of an exclusive video interview with Eric A. Adams, CEO of InMed Pharmaceuticals Inc. (CSE: IN)(CSE: IN.CN)(CNSX: IN)(OTCQB: IMLFF). In this interview, CEO Eric A. Adams talks about the company's recent breakthrough, a study in which the team was able to identify a cannabinoid drug candidate for the treatment of glaucoma; biosynthesize that cannabinoid; develop a proprietary hydrogel delivery system; and effectively apply the new drug to the eye in a positive preclinical study. (8-0)

NetworkNewsWire Announces Publication Discussing Companies Developing Novel Methods of Extracting Medicinal-Grade Cannabinoids

2017-11-01 marketwired
NEW YORK, NY--(Marketwired - Nov 1, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a client of NNW specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. (6-1)

NetworkNewsWire Announces Publication Highlighting Innovations in Cannabis R&D

2017-10-27 marketwired
NEW YORK, NY--(Marketwired - Oct 27, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a client of NNW specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. (6-0)

NetworkNewsWire Announces Publication Discussing Advanced Technology in Cannabinoid R&D

2017-10-26 marketwired
NEW YORK, NY--(Marketwired - Oct 26, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a client of NNW specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. (6-0)

NetworkNewsWire Announces Publication on the Impact of Biosynthesis on Cannabinoid Pharmaceuticals

2017-10-25 marketwired
NEW YORK, NY--(Marketwired - Oct 25, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a client of NNW specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. (38-0)

BRIEF-InMed Pharmaceuticals ‍announces additional pre-clinical results in development of INM-405

2017-10-17 reuters
* InMed Pharmaceuticals Inc - ‍announced additional pre-clinical results in development of INM-405 for treatment of pain​ (6-0)

NetworkNewsWire Announces Publication Highlighting Companies Engaged in Advanced Cannabinoid Research

2017-09-29 marketwired
NEW YORK, NY--(Marketwired - Sep 29, 2017) -  NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a client of NNW specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. (6-1)

NetworkNewsWire Announces Publication on Advances in Cannabinoid-Based Medicine

2017-09-27 marketwired
NEW YORK, NY--(Marketwired - Sep 27, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring InMed Pharmaceuticals, Inc. (CSE: IN) (OTCQB: IMLFF), a client of NNW specializing in the development of novel therapeutics leveraging the pharmacological benefits of cannabinoids. (6-0)

InMed Pharmaceuticals Added to CSE25 Index

2017-09-21 prnewswire
VANCOUVER, Sept. 21, 2017 /PRNewswire/ - InMed Pharmaceuticals, Inc. ("InMed" or the "Company") (CSE: IN; OTCQB: IMLFF), a biopharmaceutical company specializing in the research and development of novel, cannabinoid-based drug therapies, is pleased to announce that InMed has been included in the CSE25 Index. InMed qualified for the index as one of the twenty-five largest companies in the CSE Composite Index. (6-0)